產品詳情
簡單介紹：
Anti-C6orf165抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C6orf165抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-C6orf165
Cat. Number:
Anti-C6orf165抗體KL-15228R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposesAnti-C6orf165抗體 an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf165 gene product has been provisionally designated C6orf165 pending further characterization.
Also known as:
C6orf165; CF165_HUMAN; Anti-C6orf165抗體Chromosome 6 open reading frame 165; dJ382I10.1; UPF0704 protein C6orf165.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf165.
●
Predicted Molecular Weight: 71kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-C6orf165抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-C6orf165抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-C6orf165抗體must be determined by the end user.
kl352Mu01 *******調節轉錄肽(CART)多克隆抗體 Polyclonal Antibody to Cocaine And Amphetamine Regulated Transcript (CART)
kl352Mu02 *******調節轉錄肽(CART)多克隆抗體 Polyclonal Antibody to Cocaine And Amphetamine Regulated Transcript (CART)
kl352Ra01 *******調節轉錄肽(CART)多克隆抗體 Polyclonal Antibody to Cocaine And Amphetamine Regulated Transcript (CART)
kl355Mu02 甲狀腺球蛋白(TG)多克隆抗體 Polyclonal Antibody to Thyroglobulin (TG)
kl362Mu01 尾加壓素2(UST2)多克隆抗體 Polyclonal Antibody to Urotensin 2 (UST2)
kl362Mu02 尾加壓素2(UST2)多克隆抗體 Polyclonal Antibody to Urotensin 2 (UST2)
kl370Mu02 β-血小板球蛋白(βTG)多克隆抗體 Polyclonal Antibody to Beta-Thromboglobulin (bTG)
kl371Mu02 10kDa干擾素γ誘導蛋白(IP10)多克隆抗體 Polyclonal Antibody to Interferon Gamma Induced Protein 10kDa (IP10)
kl372Mu02 凝溶膠蛋白(GS)多克隆抗體 Polyclonal Antibody to Gelsolin (GS)
kl373Mu02 結蛋白(Des)多克隆抗體 Polyclonal Antibody to Desmin (Des)
kl380Gu01 血管活性腸肽(VIP)多克隆抗體 Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl380Mu02 血管活性腸肽(VIP)多克隆抗體 Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl383Mu02 磷酸肌醇-3-激酶2α肽(PI3K2α)多克隆抗體 Polyclonal Antibody to Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a)
kl384Mu02 白介素23(IL23)多克隆抗體 Polyclonal Antibody to Interleukin 23 (IL23)
kl386Mu02 脂蛋白脂酶(LIPD)多克隆抗體 Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl389Hu01 補體成分4a(C4a)多克隆抗體 Polyclonal Antibody to Complement Component 4a (C4a)
kl389Mu02 補體成分4a(C4a)多克隆抗體 Polyclonal Antibody to Complement Component 4a (C4a)
